[50th contribution of the Central Expert Committee for Drug Trade, Section Human Medicine].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone
50. Mitteilung des Zentralen Gutachterausschusses für Arzneimittelverkehr, Sektion Humanmedizin.